Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer
about
Validation of the Cancer BioChip System as a 3D siRNA screening tool for breast cancer targetsAssessment of Topoisomerase II α status in breast cancer by quantitative PCR, gene expression microarrays, immunohistochemistry, and fluorescence in situ hybridization.Prognostic significance of TOP2A gene dosage in HER-2-negative breast cancerPrognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 studySample parameters affecting the clinical relevance of RNA biomarkers in translational breast cancer research.Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer.TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancer.Quantum dot-based immunofluorescent imaging and quantitative detection of TOP2A and prognostic value in triple-negative breast cancer.Do anthracyclines still have a role in adjuvant chemotherapy of breast cancer?Use of standard markers and incorporation of molecular markers into breast cancer therapy: Consensus recommendations from an International Expert Panel.Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?Ancestry as a potential modifier of gene expression in breast tumors from Colombian women.A metastasis biomarker (MetaSite Breast™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancer.Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial.Prognostic gene expression assays in breast cancer: are two better than one?
P2860
Q31103913-FAAF1FF6-9425-412A-A557-872DC95E14D2Q34805496-DF0E02C8-2E0F-4EDC-8825-F94F7A675952Q36349584-9A004C6C-F19B-422B-8270-274532FC3F09Q36554725-74104DA3-4FCC-4BC1-BCB4-18A4196490AFQ36598709-7AE55CAE-2FD5-484C-91A0-F56216A82060Q36603829-A4B3C697-B384-4D80-AEB6-0A440F1BF9C0Q37136305-99B000A2-EA23-4942-B52B-81FD79117C82Q37376754-12DC9756-7A9A-4E35-B2CB-E858279C1640Q37822734-9D0F3536-B634-4BE3-93AA-F44B14D24667Q37862646-7AB7ECA8-3F05-41FF-B442-31040A550B32Q37989074-B780F50D-C931-4B83-B752-E879B932800FQ41498719-BDA8B9DB-933F-4E25-901D-F7F089011EBEQ43787894-56C5919F-F43A-4ABD-A216-EDDE465BB469Q55066764-A2608D70-A421-4D8B-B041-36F9E6A3F257Q55346547-1ABB51F6-5141-4BCC-A64D-07578BDEE340
P2860
Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Relationship between Topoisome ...... Chemotherapy for Breast Cancer
@ast
Relationship between Topoisome ...... Chemotherapy for Breast Cancer
@en
type
label
Relationship between Topoisome ...... Chemotherapy for Breast Cancer
@ast
Relationship between Topoisome ...... Chemotherapy for Breast Cancer
@en
prefLabel
Relationship between Topoisome ...... Chemotherapy for Breast Cancer
@ast
Relationship between Topoisome ...... Chemotherapy for Breast Cancer
@en
P2093
P2860
P1476
Relationship between Topoisome ...... Chemotherapy for Breast Cancer
@en
P2093
Barrett H Childs
Diana Brassard
Edith Perez
Frederick L Baehner
George W Sledge
Joseph A Sparano
Lawrence N Shulman
Lori J Goldstein
Nancy E Davidson
Robert Gray
P2860
P304
P356
10.1158/1078-0432.CCR-09-1450
P407
P577
2009-12-01T00:00:00Z